Diabetes mellitus-associated periodontitis: Differences between type 1 and type 2 diabetes mellitus

Journal of Periodontal Research

Volumn 46, Issue 2, 2011, Pages 164-169

  Aspriello, S D ^a   Zizzi, A ^a   Tirabassi, G ^a   Buldreghini, E ^a   Biscotti, T ^a   Faloia, E ^a   Stramazzotti, D ^a   Boscaro, M ^a   Piemontese, M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

C reactive protein; Cytokine; Diabetes mellitus; Periodontitis

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; AUTACOID; C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALVEOLAR BONE LOSS; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; GINGIVA BLEEDING; GINGIVITIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; TIME; TOOTH PLAQUE;

ADULT; AGED; ALVEOLAR BONE LOSS; ANTIHYPERTENSIVE AGENTS; C-REACTIVE PROTEIN; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GINGIVAL CREVICULAR FLUID; GINGIVAL HEMORRHAGE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION MEDIATORS; INSULIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79951886480     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2010.01324.x     Document Type: Article

References (44)

1. Mealey BL, Oates TW, American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-1303.
2. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
3. Saito T, Murakami M, Shimazaki Y et al. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol 2003;74: 1741-1746.
4. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79:1585-1591.
5. Ishimi Y, Miyaura C, Jin CH et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
6. Kurihara N, Civin C, Roodman GD. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 1991;6:257-261.
7. Wajant H, Pfeffer K, Pfizenmaier K, Scheurich P. Tumor necrosis factors in 1998. Cytokine Growth Factor Rev 1998;9:297-302.
8. Boyce BF, Li P, Yao Z et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005;54:127-131.
9. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24:8-16.
10. Salvi GE, Beck JD, Offenbacher S. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998; 3:40-50.
11. Aspriello SD, Zizzi A, Lucarini G et al. Vascular endothelial growth factor and microvessel density in periodontitis patients with and without diabetes. J Periodontol 2009;80:1783-1789.
12. Lucarini G, Zizzi A, Aspriello SD et al. Involvement of vascular endothelial growth factor, CD44 and CD133 in periodontal disease and diabetes: an immunohistochemical study. J Clin Periodontol 2009;36:3-10.
13. Rescala B, Rosalem W, Teles RP et al. Immunological and Microbiological Profiles of Chronic and Aggressive Periodontitis Subjects. J Periodontol 2010;81:1308-1316.
14. Hou LT, Liu CM, Liu BY, Lin SJ, Liao CS, Rossomando EF. Interleukin-1beta, clinical parameters and matched cellular-histopathologic changes of biopsied gingival tissue from periodontitis patients. J Periodontal Res 2003;38:247-254.
15. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000;71:1535-1545.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care 2006;29:S43-S48.
17. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
18. Lindhe J, Ranney R, Lamster I et al. Consensus Report: chronic Periodontitis. Ann Periodontol 1999;4:38.
19. Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol 1967;38:610-616.
20. Mühlemann HR, Son S. Gingival sulcus bleeding - a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15: 107-113.
21. Bozkurt FY, Berker E, Akkuş S, Bulut S. Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult periodontitis. J Periodontol 2000;71:1756-1760.
22. Güncü GN, Caglayan F, Dinçel A, Bozkurt A, Saygi S, Karabulut E. Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth. J Periodontol 2006;77:2005-2010.
23. Yücel OO, Berker E, Gariboǧlu S, Otlu H. Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol 2008;35:365-370.
24. Iacopino AM. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 2001;6:125-137.
25. Hugoson A, Thorstensson H, Falk H, Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989;16:215-223.
26. Zhong Y, Slade GD, Beck JD, Offenbacher S. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. J Clin Periodontol 2007;34:285-293.
27. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ et al. Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol 2004;75: 1203-1208.
28. Ladeia AM, Stefanelli E, Ladeia-Frota C, Moreira A, Hiltner A, Adan L. Association between elevated serum C-reactive protein and triglyceride levels in young subjects with type 1 diabetes. Diabetes Care 2006;29:424-426.
29. Wu T, Dorn JP, Donahue RP, Sempos CT, Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2002;155:65-71.
30. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
31. Netea MG, Hancu N, Blok WL et al. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals. Cytokine 1997;9:284-287.
32. Aribi M, Moulessehoul S, Kendouci-Tani M, Benabadji AB, Hichami A, Khan NA. Relationship between interleukin-1beta and lipids in type 1 diabetic patients. Med Sci Monit 2007;13:CR372-CR378.
33. Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 2006;3:17.
34. Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Mediators Inflamm 2006;2006:59206.
35. Lee MS, Chang I, Kim S. Death effectors of beta-cell apoptosis in type 1 diabetes. Mol Genet Metab 2004;83:82-92.
36. Monnier VM, Glomb M, Elgawish A, Sell DR. The mechanism of collagen cross-linking in diabetes. A puzzle nearing resolution. Diabetes 1996;45:S67-S72.
37. Schmidt AM, Hori O, Cao R et al. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996;45:S77-S80.
38. Schmidt AM, Yan SD, Wautier J-L, Stern D. Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-497.
39. Hatipoǧlu H, Yamalik N, Berberoǧlu A, Eratalay K. Impact of the distinct sampling area on volumetric features of gingival crevicular fluid. J Periodontol 2007;78:705-715.
40. Ozkavaf A, Aras H, Huri CB et al. Relationship between the quantity of gingival crevicular fluid and clinical periodontal status. J Oral Sci 2000;42:231-238.
41. Armitage GC, Cullinan MP. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000 2010;53:12-27.
42. Lang N, Bartold PM, Cullinan M et al. Consensus Report: aggressive Periodontitis. Ann Periodontol 1999;4:53.
43. Türkoǧlu O, Emingil G, Kütükçüler N, Atilla G. Gingival crevicular fluid levels of cathelicidin LL-37 and interleukin-18 in patients with chronic periodontitis. J Periodontol 2009;80:969-976.
44. Lalla E, Cheng B, Lal S et al. Diabetes mellitus promotes periodontal destruction in children. J Clin Periodontol 2007;34: 294-298.